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Abstract
Background: Recently, several members of a vertebrate protein family containing a six trans-
membrane (6TM) domain and involved in apoptosis and cancer (e.g. STEAP, STAMP1, TSAP6), have
been identified in Golgi and cytoplasmic membranes. The exact function of these proteins remains
unknown.
Methods: We related this 6TM domain to distant protein families using intermediate sequences
and methods of iterative profile sequence similarity search.
Results: Here we show for the first time that this 6TM domain is homolog to the 6TM heme
binding domain of both the NADPH oxidase (Nox) family and the YedZ family of bacterial
oxidoreductases.
Conclusions: This finding gives novel insights about the existence of a previously undetected
electron transfer system involved in apoptosis and cancer, and suggests further steps in the
experimental characterization of these evolutionarily related families.
Background
A family of vertebrate proteins containing a six transmem-
brane domain (6TM) has been recently implicated in
apoptosis and cancer. Up to date, this family contains four
vertebrate members: STEAP, STAMP1/STEAP2, TIARP and
TSAP6/pHyde. STEAP (six-transmembrane epithelial anti-
gen of the prostate) was the first described member of this
family and identified as a prostate-specific cell-surface
antigen overexpressed in cancer, located at the cell-cell
junction of the secretory epithelium of prostate, and
found as well in both colon and bladder cancer cell lines
[1,2]. STAMP1 (six transmembrane protein of prostate 1),
also known as STEAP2, also overexpressed in prostate can-
cer, has been located in the trans-Golgi network and shut-
tles to plasma membranes, which suggest a role in the
secretory/endocytic pathways [3,4]. TIARP (Tumor necro-
sis factor-alpha-induced adipose-related protein) is a cell
surface protein induced by TNF-α and IL-6, probably
implicated in resistance to insulin [5,6]. TSAP6 (tumor
suppressor activated pathway-6), also known as pHyde
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[7-10], is a p53 inducible protein which regulates apopto-
sis and the cell cycle via direct interaction with Nix (a pro-
apoptotic Bcl-2 related protein) and Myt1 kinase (a nega-
tive regulator of the G2/M transition) [9]. TSAP6 has been
shown to be interacting with TCTP (Translationally con-
trolled tumor protein) and could be implicated in its
secretion [10].
In this work we present evidence of remote homology of
this family to other two families: the mainly eukaryotic
Nox and the bacterial YedZ (Fig. 1), both involved in
redox functions [11-17]. The Nox family is involved in the
production of reactive oxygen species (ROS) [11,12]. The
first member of the family (gp91phox) was discovered in
phagocytes and contains an N-terminal transmembrane
heme binding domain and two C-terminal domains with
binding sites for both flavin adenine dinucleotide (FAD)
and NADPH (Fig. 2) [11-13]. Originally, ROS were
thought to be used just as a mechanism of host defence.
The discovery of gp91phox homologues in several other
tissues has suggested their implication in many other
functions, such us signal transduction, cancer, mitogenic
signalling, cellular growth, angiogenesis, and modifica-
tion of extracellular matrix proteins [11-14]. Regarding
the bacterial YedZ family, the only experimentally charac-
terized member so far is the Escherichia coli YedZ protein,
which binds a single heme and is involved in electron
transfer to the molybdopterin cofactor in YedY, its operon
neighbour gene [16-18]. The exact function of the operon
YedZ/YedY remains unknown.
Methods
To do the sequence analysis of the new domain we took
advantage of the possibility of connecting distant protein
Representative multiple alignment of the ACRATA domain Figure 1
Representative multiple alignment of the ACRATA domain. It is viewed with the Belvu program [33]. The colouring 
scheme indicates average BLOSUM62 score (correlated to amino acid conservation) in each alignment column: cyan (greater 
than 3), light red (between 3 and 1.5) and light green (between 1.5 and 0.5). The limits of the domains are indicated by the res-
idue positions on each side. The TMHMM helix transmembrane [29, 30] consensus prediction is shown below the alignment. 
The asterisks above the alignment mark the conserved histidine residues mentioned in the text. Different groups of the 
ACRATA sequences are shown by coloured lines to the left of the alignment: red, YedZ family; yellow, STEAP family; violet, 
Nox family. The sequences are named with their swissprot or sptrembl identifiers, and also, if necessary, with their gene name. 
Species abbreviations: Homsa, Homo sapiens; Glovi, Gloeobacter violaceus; Anasp, Anabaena sp.; Cloac, Clostridium acetobutylicum; 
Musmu, Mus musculus; Xenla, Xenopus laevis; Sacce, Saccharomyces cerevisiae; Emeni, Emericella nidulans; Dicdi, Dictyostelium dis-
coideum; Caeel, Caenorhabditis elegans; Drome, Drosophila melanogaster; Arath, Arabidopsis thaliana. Complementary information 
is accessible at: http://www.pdg.cnb.uam.es/STEAP.
PLLIRTRRLLGLWCFAWATLHLTSYALLELGV..................................NNLALLGKELITRPYLTLGIISWVILLALAFTSTQAMQRK.LG.KHWQQLH.NFVYLVAI.LAPIHYL YEDZ_ECOLI   71 166
PGWIVVRRQLGLWCFAYVVLHMTMYALFILG...................................LDWGQLGVELVKRPYIIVGALAFLGLLALAVTSNRYSQRR.LG.SRWKKLH.RLVYVILG.LGLLHMF Y986_PSESM   66 160
SGWIVVRRQLGLWVFAYIVLHILCYLFFILG...................................LDWGQLAVELRKRPYIIVGALGFLGLLVLAVTSNRYSQRR.LG.ARWKKLH.RLVYAVLG.LGLLHFL YAH5_PSEPK   66 160
PGWIAVRRQLGLWCFTYVLLHLSAYYVFILG...................................LDWGQLGIELSKRPYIIVGMLGFVCLFLLAITSNRFAMRK.LG.SRWKKLH.RLVYLILG.LGLLHML YAJ1_PSEAE   66 160
PQLQVLRRALGLWAWFYVVLHVYAYLALELG...................................YDFSLFVQELVNRGYLIIGAIAFLILTLMALSSWSYLKLK.MG.KWWFYLH.QLGYYALL.LGAIHYV Y538_PASMU   68 162
AVVIRFRRMLGLYAFFYATVHLAAYLTLDLR...................................GFWTQIFEEILKRPYITVGFAAWLLLMPLAITSTQGWMRR.LK.RNWGRLH.MLIYPIGL.LAVLHFW YG46_XANAC   77 171
PALVRLRRMCGLFAFFYGSLHFLAWVWWDRG...................................LDPVSMLQDVGERPFITVGFAAFVLMAALAATSTQWAMRK.LG.KRWQVLH.RAVYAIGL.LAILHFW Y1G5_BORBR   74 168
NWLIRIRRMLGLYTFFYGTLHFLIWLLVDRG...................................LDPASMVKDIAKRPFITVGFAAFVLMIPLAATSTNAMVRR.LGGRRWQWLH.RLVYVTGV.LGILHYW YT80_RALSO   74 169
PRLVRFRRTVGLFAFAYVALHLLAYVGIDL...................................FFDWNQLWKDILKRPFITLGMLGFMLLIPLAVTSTNGWVIR.MGRAAWSRLH.RLVYLIVP.LGVAHYY YR47_CAUCR   78 173
ITLLRYRRALGLLAFYYALMHFTTYMVLDQG...................................LNLSAIITDIVRRPFITIGMISLALLVPLALTSNNWSIRK.LG.RRWSSLH.KLVYIAIA.GSAVHFL Y304_BRUME   78 172
VNWLRYRRALGLLAFYYVMMHFLTYMVLDQT...................................LLLPAIVADIARRPFITIGMAALVLLIPLAVTSNIWSIRR.LG.QRWNKLH.RLVYVIAA.AGALHFA YD82_RHIME   74 168
VNLIAYRRALGLIAFYYVLAHFTVYLVLDRG...................................LILGSIAGDILKRPYIMLGMAGLIILIPLALTSNRWSIRR.LG.SRWNTLH.KLVYLVLI.VGVLHFV YJ20_AGRT5   77 171
TWAARIRKALGLLAAFYAVLHFGIYLRGQD....................................FSLGRIWEDVTERPFITSGFAALLLLLPLVLTSGKGSVRR.LGFARWTLLH.RLVYLAAA.LGALHYW YP37_DEIRA   71 165
PGLLQERRYLGLLTFAFSVLHTWSQIEH..................................VLGGSLDGMFFLPRDMQFGVELGIFALLAMLPLALTSTDWAVRT.LK.GAWKGLH.QGVFFAAF.LIVLHTL Q7NFG8_Glovi   82 177
ASPLNYRRALGVGAFVLSVVHTTHMIQHS..................................LDWNFAAFFFLPPQFQIGMAAGAVALILMTPAAFTSWESWQKS.LG.KYWRQIH.LLSVPALL.LSAIHAV Q8YN59_Anasp  273 368
KKLVAIRAQMAIMASIFIFPHVCIYLYYVLK...............................YTFPEVIDKGSIELFTAAYILAGIIAFIIMMPLFITSLK.KVRRKMNGVKWKKLQ.RWAYLFYL.LVYGHIL Q97LK5_Cloac   91 190
QRVMGLRAELAITAAILTLGHNIAH..................................GRDYLVRLCGSTGDLSTGFLVAGAVSMVLVLLMSILAVTSFK.VVRRRMGAKTWKRVQ.RLAYLFYG.LTYVHLS Y572_TREPA   87 183
DKWMLTRKQFGLLSFFFAVLHAIYSLSYPMRRSYRYKLLN................WAYQQVQQNKEDAWIEHDVWRMEIYVSLGIVGLAILALLAVTSIP.SVSDSLTWREFHYIQSKLGIVSLL.LGTIHAL STEA_HUMAN  155 270
ETWLQCRKQLGLLSFFFAMVHVAYSLCLPMRRSERYLFLN................MAYQQVHANIENSWNEEEVWRIEMYISFGIMSLGLLSLLAVTSIP.SVSNALNWREFSFIQSTLGYVALL.ISTFHVL Q8NFT2_STEAP2_Homsa  296 411
DHWLQHRKQIGLLSFFCAALHALYSFCLPLRRAHRYDLVN................LAVKQVLANKSHLWVEEEVWRMEIYLSLGVLALGTLSLLAVTSLP.SIANSLNWREFSFVQSSLGFVALV.LSTLHTL Q86SF6_TSAP6_Homsa  296 411
DHWMLCRKQLGLVALGFAFLHVIYTLVIPIRYYVRWRLRN................ATITQALTNKDSPFITSYAWINDSYLALGILGFFLFLLLGITSLP.SVSNMVNWREFRFVQSKLGYLTLV.LCTAHTL Q91W31_TIARP_Musmu  284 399
DTWMLCRKQLGLVALAYAFLHAIYTLVMPIRYYVRWWSNN................YIITQIKTNNTYEFLNYYAWLSDSYVALGILGFFFYVLLGITSLP.SVSNAVNWREFRFVQSKLGYLTLV.LCTAHTL Q6PAY4_Xenla  283 398
DQWMLCRKQLGLIALSYALLHAIYTLVIPIRYYVRYRINS................NIITQILKNETRTFDNTLAWRTDAYIALGILGFFFYVLLGITSLP.SVSNAVNWREFRFVQSKLGYLTLV.LCTGHAL Q6P7H1_Xenla  284 399
LALLPLHKWISRIVVLESILHTWFYL......................................YYMYINDTLYVKMRKLPNIYGVIALGLFLLIAITSVR.YARR.WSYRVFYYVH.YVSTWLILVFLHYHAR Q12209_L2114_Sacce  146 238
TDFIPFHKWFSRIITVIGLLHGIFFIIKW...................................AIDDNVSLKQKLILKTFNFAGFIISILVLFLLICSIG.PMRR.YNYRLFYIVH.NLVNVAFILLTPIHSR YGR0_YEAST  130 225
DRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTK.TIRR.SYFEVFWYTH.HLFVIFFI.GLAIHGA C24B_HUMAN   94 223
DHNLTFHKLVAYMICLHTAIHIIAHLFNFDCYSRSRQATDGSLASILSSLSHDEK.KGGSWLNPIQSRNTTVEYVTFTSIAGLTGVIMTIALILMVTSATE.FIRR.SYFEVFWYTH.HLFIFYIL.GLGIHGI NOX1_HUMAN   95 223
DENIWFHRQVAYATLVFTILHVAAHYVNFYN..............................IERKQLRPETALQIHYAQPAGVTGHVMLFCMMLMYTTAHH.RIRQ.QSFETFWYTH.HLFIPFLL.GLYTHAT Q8J0N4_noxA_Emeni   91 190
DKNIVFHKLIAWVICFATFGHVMAHFNNFRLYQDITP..................QEYKRILGIDYPNLTPIKYA.FATLAGWTGHVVCIVMVLMYTSAVE.SIRR.PMFEGFWYTH.HLFVVFFG.LLVVHGL Q9XYS3_Dicdi   95 205
DKSRTFHITCGVTICIFSGVHVAAHLVNALNFSVNYSED...................FVELNAARYRDEDPRKLLFTTVPGLTGVCMVVVLFLMITASTY.AIRV.SNYDIFWYTH.NLFFVFYM.LLTLHVS Q7Z7G3_NOX4_Homsa   99 209
DKYMTFHKLIGYTLIIASFLHTIGWIVGMAVATGKPDN..................IFYDCLAPHFKFRPTVWEMIFNSLPGVTGFIMISFLIIMAILSLK.IIRK.SNFELFYYSH.HLFIGFYV.LLILHGT Q86MX0_Dicdi  659 770
DSAIAFHKIVALFAAFWATLHTVGHCVNFYHVGTQSQEGLAC...............LFQEAFFGSNFLPSISYWFFSTITGLTGIALVAVMCIIYVFALP.CFIK.RAYHAFRLTH.LLNIAFYA.LTLLHGL O61213_Caeel 1067 1181
DSHIQFHKIAACTALFFSVLHTVGHIVNFYHVSTQSHENLRC...............LTREVHFASDYKPDITFWLFQTVTGTTGVMLFIIMCIIFVFAHP.TIRK.KAYNFFWNMH.TLYIGLYL.LSLIHGL Q9VQH2_Drome 1047 1161
DAAVDFHRLIASTAIVLTVLHSVGHVVNVYLFSISPLSVLSC.............LFPGLFHDDGSELPQKYYWWFFQTVPGLTGVVLLLILAIMYVFASH.HFRR.RSFRGFWLTH.HLYILLYV.LLIIHGS Q9NRD9_DUOX1_Homsa 1124 1240
DAAVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLAC.............IFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLAIMYVFASH.HFRR.RSFRGFWLTH.HLYILLYA.LLIIHGS Q9UHF9_Homsa  783 899
DHHVYLHKLTGITISVLSLIHTIMHLFNFSIIVINDPNI................NAGHYTIGEWLLTDRPGLFGLIPGCANPTGVALLAILVVMFVCSQP.FVRRKGSFEVFYWTH.LLYVPFWI.LCLFHGP Q9V7N2_Drome  339 453
DQNIQFHQLMGYVVVGLSLVHTVAHTVNFVLQAQA....................EASPFQFWELLLTTRPGIGW.VHGSASPTGVALLLLLLLMFICSSS.CIRRSGHFEVFYWTH.LSYLLVWL.LLIFHGP Q96PH1_Homsa  308 417
ESSIKYHIWLGHLVMIIFTSHGLCYFIYW.................................ISKNQLVSKMLEWDRTAVSNLAGEIALVAGLMMWVTTYP.KIRR.RLFEVFFYSH.YLYIVFML.FFVFHVG P92950_FRO1_Arath  203 299
ESSIKYHIWLGHMVMALFTVHGLCYIIYW..................................ASMHEISQMIMWDTKGVSNLAGEIALAAGLVMWATTYP.KIRR.RFFEVFFYTH.YLYIVFML.FFVLHVG P92949_FRO2_Arath  213 308
TSFIMFHKWLGRMMFLDAMIHGSAYT......................................SYTVANKTWATSKNRLYWQFGVAALCLAGTMVFFSFA.VFRK.YFYEAFLFLH.IVLGAMFFYACWEHVV FRE2_YEAST  310 402
TSFIMFHKWLGRMMFLDAVIHGAAYT......................................SYSVFYKDWAASKEETYWQFGVAALCIVGVMVFFSLA.MFRK.FFYEAFLFLH.IVLGALFFYTCWEHVV FRE3_YEAST  310 402
TSFIVFHKWLGRMMFLDAIIHAAGFT......................................NYYLYYKKWNTVRLRVYWKFGIATTCLAGMLIFFSIA.AFRR.HYYETFMALH.IVFAALFLYTCWEHVT FRE4_YEAST  303 395
TAFITYHKWLGRFMLVDCTIHAIGYT......................................YHAYIENYWKYVKYSDLWTSGRHAMIIVGILVFFSFF.FFRR.HYYELFVITH.IILAIGFFHACWKHCY FRE5_YEAST  304 396
NSFISFHKWIGRIMVLNATIHSLSYS......................................LFAIINHAFKISNKQLYWKFGIASITVLCVLLVLSLG.IVRK.RHYEFFLYTH.IILALLFFYCCWQHVK FRE6_YEAST  317 409
STFNFYHKWSAYVCFMLAVVHSIVMTASGVKR......................................GVFQSLVRKFYFRWGIVATILMSIIIFQSEK.VFRN.RGYEIFLLIH.KAMNIMFIIAMYYHCH FRE1_YEAST  288 380
ATFIMYHRWISRVDVLLIIVHAITFSVS......................................DKATGKYKNRMKRDFMIWGTVSTICGGFILFQAML.FFRR.KCYEVFFLIH.IVLVVFFVVGGYYHLE FREL_CANAL  269 361
EKMNYVHRRLSQYAIMIGAIHGFAYI........................................GLAAQGKRALLTARVTIIGYVILGLMVIMIVSSLP.FFRR.RFYEWFFVLH.HMCSIGFLITIWLHHR FRP1_SCHPO  151 241
EKINIYHQWASILCLFFSWVHVIPFLRQARH..................................EGGYERMHQRWKASDMWRSGVPPILFLNLLWLSSLP.IARR.HFYEIFLQLH.WILAVGFYISLFYHVY FRE7_YEAST  191 287
DLILQFHRYTSIVAFLFLLAHPIILFINN.................................PETLQLLNFFQAPWRAR....AAVIATLALIAIIVTSIW.RKQLNIGYENWRIAH.GILAVIIVSFGLGHVL Q8YTT0_Anasp   80 174
SYIVKAHRLFGYISVGFLLFHPLLEVLPR..............................QFEGSIQPFDAFWKIITTDNSAILLGIAGWAVMLTLAVTSVL.RKRLFKNYRKWRTFH.GILAVVLITVVGYHVL YE62_ARCFU   29 130
TM III TM IV TM V
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families via intermediate sequences [19] and methods of
iterative profile sequence similarity search: HMMer
[20,21] and PSI-BLAST [22] over the Uniprot 90% non
redundant sequence database [23]. We used NAIL to view
and analyse the HMMer results [24]. The alignment of
transmembrane regions using standard substitution
matrices might be inaccurate because of the different roles
played by amino acids in globular proteins and in trans-
membrane media [25]. In the case of the ACRATA
domain, the regions to be aligned mostly consist of amino
acids located in transmembrane regions (Fig. 1). For this
reason, we used a method based on a hidden Markov
model (HMMer hmmalign), which does not rely on a gen-
eral substitution matrix [20,21], using as a guide both the
transmembrane predictions from TMHMM [26,27] and
the results of multiple sequence alignment using T-Coffee
[28,29]. The genomic neighborhood of the bacterial
sequences (YedZ family) was analyzed to find potentially
related genes in operons using STRING [17,18].
Results
The global hidden Markov profile [20,21] generated for
STEAP and related vertebrate proteins (STEAP family,
henceforth) localized the first bacterial sequence (SpT-
rembl Q7VKI9 from Haemophilus ducreyi) with an E-value
of 0.63. This protein belongs to the large YedZ family of
bacterial oxidoreductases. The corresponding YedZ global
profile detected the STEAP family (most similar member:
SpTrembl Q8IUE7, human STAMP1) with an E-value of
0.00087. The global profile of STEAP and YedZ detected
the Nox family with an E-value of 0.032 and the corre-
sponding Nox global profile localized the YedZ family
with an E-value of 0.007 (Fig. 3). Only the regions from
transmembranes 3 to 5 were considered to build the pro-
files because the transmembranes 1, 2 and 6 are highly
variable among families. We have named this 6TM
domain the ACRATA domain after Apoptosis, Cancer and
Redox Associated TransmembrAne domain.
To investigate the consistency of our results we performed
iterative database searches using the PSI-BLAST program
[22]. We used as query the most conserved region of the
ACRATA domain in E. coli YedZ protein (residues 71–
166). These searches detected all of the ACRATA domain-
containing families after 15 iterations (using a cut-off of E
= 0.005 for the inclusion of retrieved sequences in the pro-
file). None of these profile searches retrieved new
Schematic representation of the domain architecture and  common features in representative proteins containing the  ACRATA domain Figure 2
Schematic representation of the domain architec-
ture and common features in representative proteins 
containing the ACRATA domain. The representative 
sequences selected correspond to: YEDZ, 
SW:YEDZ_ECOLI; STEAP, SW:STEA_HUMAN; TSAP6, 
SP:Q80ZF3; NOX1, SW:NOX1_HUMAN; NOX5, 
SP:Q96PH2; DUOX1, SP:Q9NRD9. NOX1, NOX5, and 
DUOX1, belong to the Nox family. The proteins are drawn 
approximately to scale. The domains are named and located 
according to the Pfam and SMART protein domain databases 
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HMMer E-Values between the ACRATA domain containing  families Figure 3
HMMer E-Values between the ACRATA domain con-
taining families. The numbers correspond to HMMer E-
values from global profile search results [20, 21] that connect 
independently each family with the others. The arrows indi-
cate the profile search direction, for example: the YedZ fam-
ily profile search finds sequences of the STEAP family with a 
0.00087 E-value and the global profile of the YedZ/STEAP 
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unrelated sequences, and reciprocal searches produced
convergent results. Therefore, we have concluded that
ACRATA is a previously undetected, conserved domain
that is commonly found in members of the STEAP, YedZ
and Nox protein families. The similarity between these
proteins was suspected before [30]. However, no align-
ment, domain definition or substantial statistical evi-
dence was provided to demonstrate the evolutionary
relationships of these proteins.
The complete conservation of two histidines in all
ACRATA domain containing proteins (Fig. 1) indicates
that the STEAP protein family could bind at least an heme
group, as was previously experimentally characterized for
Nox and YedZ families [13,16], or for other analogous
proteins such as cytochromes [31].
Discussion
Experimental evidence show that Nox and YedZ families
share heme binding capabilities and also involvement in
electron transfer chains [11-13,16]. For the STEAP family,
the electron transfer capability is consistent with the pres-
ence of an N-terminal cytoplasmic NADP oxidoreductase
coenzyme F420 dependent domain, being the only excep-
tion the STEAP protein itself (Fig. 2). Therefore we con-
clude that ACRATA domain is a heme binding 6TM
domain that originated before the onset of eukaryotes
(ancestral, YedZ), transmitted by vertical descent in a con-
ventional manner (Nox family), and further expanded in
vertebrates (STEAP family) (Fig. 4).
Although the mechanism of action of the ACRATA
domain could be the same in all the proteins containing
it, its variable cellular role is made conspicuous by the dif-
ferent effects produced by the modifications in the expres-
sion of the corresponding genes. For example, the knock-
out of the whole YedYZ operon seems not to affect E. coli
in a number of conditions tested (Brokx, S.J. and Weiner,
J.H. personal communication). Very differently, changes
in the expression patterns of human genes containing the
ACRATA domain could be related with apoptosis or can-
cer [1-14]. The well known functional flexibility of oxi-
doreductases is exemplified in bacterial proteins such as
cupredoxins and cytochromes, normally involved in elec-
tron transfer during respiration but that can enter in
eukaryotic cells to induce apoptosis or inhibition of cell
growth [32], or in the Nox family, with functions as differ-
ent as host defence in phagocytes or extracellular matrix
modification [11,12].
Conclusions
We have described for the first time a 6TM domain present
in three protein families (STEAP, YedZ and Nox): the
ACRATA domain. The common functions of the proteins
of those families suggest that this domain is involved in
electron transfer, mediated by its heme binding
capability. We hypothesize that STEAP, STAMP1, TSAP6,
and TIARP have this function, and that they form part of
electron transfer systems involved in cellular regulation,
apoptosis, and cancer. Additional experimental
approaches using different members of the ACRATA
domain-containing families are required to confirm these
hypotheses.
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Phylogenetic tree of selected ACRATA domain containing  proteins Figure 4
Phylogenetic tree of selected ACRATA domain con-
taining proteins. The scale bar represents the number of 
inferred substitutions per 100 sites (amino acid residues). 
The tree branches for YedZ proteins are in red, STEAP 
branches are in yellow, and Nox branches are in violet. 
Organism name abbreviations are as in Fig. 1. We generated 
trees using a Bayesian, Neighbor Joining, and Minimum Evolu-
tion methods, and found that all three gave the same topol-
ogy suggesting that the overall structure of the tree is 
correct. For illustrative purposes only the Neighbor Joining 
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